Pfizer is planning to submit its data for COVID-19 vaccine approval to the FDA for emergency use authorization in all school-aged children by the end of this month, or early October.
CNN reports that the pharmaceutical company will submit studies conducted on children ages 5 to 11.
Pfizer’s COVID vaccine was granted emergency use in children ages 12-15 and is fully approved for people 16-years-old and up.
Pfizer is also gathering data for its vaccine for babies as young as six-months-old.
Right now, there is no vaccine available for anyone under 12.